Prothrombotic effects of tumor necrosis factor alpha in vivo are amplified by the absence of TNF-alpha receptor subtype 1 and require TNF-alpha receptor subtype 2

被引：0
|
作者：
Joachim Pircher
Monika Merkle
Markus Wörnle
Andrea Ribeiro
Thomas Czermak
Yvonn Stampnik
Hanna Mannell
Markus Niemeyer
Volker Vielhauer
Florian Krötz
机构：
[1] Ludwig Maximilians University München,Medizinische Klinik und Poliklinik IV, Innenstadt
[2] Ludwig Maximilians University München,Walter Brendel Centre of Experimental Medicine
[3] Technische Universität München,Department of Gynecology, Klinikum rechts der Isar
[4] Clinic Starnberg,Invasive Cardiology
来源：
Arthritis Research & Therapy | / 14卷
关键词：
Tissue Factor; Soluble Mediator; Prothrombotic Effect; Dorsal Skinfold Chamber; Carotid Artery Catheter;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Is there a role for tumor necrosis factor-alpha (TNF-alpha) in oral lichen planus?
    Sugermann, PB
    Savage, NW
    Seymour, GJ
    Walsh, LJ
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 1996, 25 (05) : 219 - 224
  • [32] SYNTHESIS OF TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) BY HUMAN MONOCYTES INVITRO
    MISUNO, NI
    OSIPOVICH, OA
    IDELSON, GL
    SUDARIKOV, AB
    KOLESNIKOVA, TS
    PANYUTICH, AV
    VOITENOK, NN
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 1991, 112 (09) : 1302 - 1305
  • [33] PLASMA TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) LEVELS IN PATIENTS WITH BURNS
    ENDO, S
    INADA, K
    YAMADA, Y
    KASAI, T
    TAKAKUWA, T
    NAKAE, H
    KIKUCHI, M
    HOSHI, S
    SUZUKI, M
    YAMASHITA, H
    YOSHIDA, M
    BURNS, 1993, 19 (02) : 124 - 127
  • [34] STIMULATION OF FIBROBLAST CHEMOTAXIS BY HUMAN RECOMBINANT TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) AND A SYNTHETIC TNF-ALPHA 31-68 PEPTIDE
    POSTLETHWAITE, AE
    SEYER, JM
    JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (06): : 1749 - 1756
  • [35] Gene polymorphism at position -308 of the tumor-necrosis-factor-alpha (TNF-alpha) in Multiple Sclerosis and it's influence on the regulation of TNF-alpha production
    Braun, N
    Michel, U
    Ernst, BP
    Metzner, R
    Bitsch, A
    Weber, F
    Rieckmann, P
    NEUROSCIENCE LETTERS, 1996, 215 (02) : 75 - 78
  • [36] CAN TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) BE RELIABLY MEASURED IN BLOOD
    ELBORN, JS
    DELAMARE, F
    BELL, SC
    SHALE, DJ
    PEDIATRIC PULMONOLOGY, 1995, 19 (04) : 226 - 230
  • [37] NEUTRALIZATION OF TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) ACTION ON CELL-PROLIFERATION IN RAT BLASTOCYSTS BY ANTISENSE OLIGODEOXYRIBONUCLEOTIDES DIRECTED AGAINST TNF-ALPHA P60 RECEPTOR
    PAMPFER, S
    VANDERHEYDEN, I
    VESELA, J
    DEHERTOGH, R
    BIOLOGY OF REPRODUCTION, 1995, 52 (06) : 1316 - 1326
  • [38] TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) INHIBITS EXPRESSION OF MOUSE PLACENTAL LACTOGEN-II THROUGH TNF-ALPHA TYPE-I BUT NOT TYPE-II RECEPTOR
    YAMAGUCHI, M
    KURACHI, H
    TADOKORO, C
    SAKATA, M
    YOSHIMOTO, Y
    MASUMOTO, N
    TASAKA, K
    MIYAKE, A
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 202 (03) : 1599 - 1605
  • [39] Interleukin-1 stimulates tumor necrosis factor-alpha (TNF-alpha) release from cytotrophoblastic BeWo cells independently of induction of the TNF-alpha mRNA
    Knofler, M
    Kiss, H
    Mosl, B
    Egarter, C
    Husslein, P
    FEBS LETTERS, 1997, 405 (02) : 213 - 218
  • [40] Tumor necrosis factor-alpha (TNF-alpha) decreases expression of the vascular endothelial growth factor (VEGF) receptor flk-1.
    Patterson, C
    Perrella, MA
    Lee, ME
    Haber, E
    FASEB JOURNAL, 1996, 10 (03): : 3140 - 3140
12345